Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Stock Overview
Explore Park Ha Biological Technology Co., Ltd. Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)
Key Financials
Key Financials
Market Cap
2.2M
P/E Ratio
-0.03
EPS (TTM)
$-1921.94
ROE
-1.74%
BYAH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ: BYAH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Park Ha Biological Technology Co., Ltd. Ordinary Shares's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BYAH on the NASDAQ shows an RSI of 68.80, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.37 for the NASDAQ listing.
Key metrics behind Park Ha Biological Technology Co., Ltd. Ordinary Shares's NASDAQ-traded stock include a P/E ratio of -0.03 and a market capitalization of 2.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BYAH on the NASDAQ.